Q2 2024 Gene, Cell, + RNA Therapy Landscape Report
レポート
商業化支援サービス
In this report, by Citeline and the American Society of Gene & Cell Therapy (ASGCT), new approvals in Q2 2024 were focused on the RNA landscape.